|
gptkbp:instanceOf
|
gptkb:drug
amphetamine
|
|
gptkbp:appearance
|
bluish-white rocks
clear crystals
|
|
gptkbp:boilingPoint
|
215 °C
|
|
gptkbp:broadcastOn
|
gptkb:Schedule_II_(US)
|
|
gptkbp:CASNumber
|
537-46-2
|
|
gptkbp:cause
|
death
heart attack
memory loss
stroke
anxiety
paranoia
weight loss
insomnia
hallucinations
agitation
violent behavior
|
|
gptkbp:chemicalFormula
|
C10H15N
|
|
gptkbp:commonName
|
crystal methamphetamine
|
|
gptkbp:controlledSubstanceSchedule
|
yes
|
|
gptkbp:discoveredBy
|
gptkb:Nagai_Nagayoshi
|
|
gptkbp:discoveredIn
|
1893
|
|
gptkbp:effect
|
increased energy
euphoria
decreased appetite
increased alertness
|
|
gptkbp:hasAddictivePotential
|
high
|
|
gptkbp:hasStreet
|
gptkb:glass
ice
tina
|
|
gptkbp:hasUNII
|
7B8A8UQM1F
|
|
gptkbp:hasWithdrawalSymptom
|
gptkb:depression
fatigue
increased appetite
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
crystal meth
|
|
gptkbp:isAbusedDrug
|
yes
|
|
gptkbp:legalStatus
|
illegal in most countries
|
|
gptkbp:meltingPoint
|
170 °C
|
|
gptkbp:molecularWeight
|
149.24 g/mol
|
|
gptkbp:PubChem_CID
|
441457
|
|
gptkbp:relatedTo
|
gptkb:methamphetamine_hydrochloride
amphetamine
|
|
gptkbp:riskFactor
|
addiction
skin sores
psychosis
dental problems
cardiovascular problems
|
|
gptkbp:routeOfAdministration
|
smoked
ingested
injected
snorted
|
|
gptkbp:usedFor
|
recreational purposes
treatment of ADHD (rarely)
treatment of obesity (rarely)
|
|
gptkbp:bfsParent
|
gptkb:shabu
|
|
gptkbp:bfsLayer
|
7
|